Pillstats
Rx only · Injection, Solution · Intramuscular

Succinylcholine Chloride

Brands: Anectine · Quelicin · Succinylcholine Chloride Dihydrate

25 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US33 NDCs
25 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)10154
US makers25 labelers
Packages40
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

4.6K9.3K14K19K2025 Q12025 Q22025 Q32025 Q42026 Q1
9.7K
Rx · 2026 Q1
73K
Units dispensed
-40%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it25 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Somerset Therapeutics, LLCunknown4SUPPLYING
Medical Purchasing Solutions, LLCunknown4SUPPLYING
Nordic Pharma, Inc.unknown4SUPPLYING
Fresenius Kabi USA, LLCunknown3SUPPLYING
Lifestar Pharma LLCunknown2SUPPLYING
Meitheal Pharmaceuticals Inc.unknown2SUPPLYING
Baxter Healthcare Corporationunknown2SUPPLYING
Sandoz Incunknown2SUPPLYING
Amneal Pharmaceuticals LLCunknown1SUPPLYING
Hospira, Inc.unknown1SUPPLYING
Piramal Critical Care Incunknown1SUPPLYING
Gland Pharma Limitedunknown1SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown1SUPPLYING
REMEDYREPACK INC.repackager1SUPPLYING
Henry Schein Inc.unknown1SUPPLYING

+ 10 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Aug 27, 2025
    RECALLRecall (Class II): Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL), Rx only, 10 mL Multiple-dose Vial, Sterile, Manufactur…

    Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity. — Recalling firm: Zydus Pharmaceuticals (USA) Inc — MS, OH, LA, and Puerto Rico

  • Jun 15, 2017
    RECALLRecall (Class II): Succinylcholine Chloride Injection, USP 200 mg (20 mg/mL) Quelicin Multiple-dose vial, 10 mL, For I.V. or I.M. use. a…

    Lack of Sterility Assurance — Recalling firm: Hospira a Pfizer Company — U.S. (including Puerto Rico), Dutch Antilles, Barbados, Canada, Philippines, Kuwait, and Singapore

  • Mar 15, 2016
    RECALLRecall (Class III): Quelicin (Succinylcholine Chloride) Injection, USP 200 mg. (20 mg/mL), 10 mL Multiple-dose vial, packaged in 25 Unit vi…

    Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for the lot number and/or expiration date to be faded or missing from the primary label on the glass vial. — Recalling firm: Hospira Inc. — Nationwide

  • Feb 26, 2013
    RECALLRecall (Class II): QUELICIN (succinylcholine chloride) Injection, USP, 200 mg (20 mg/mL) 10 mL, Rx only, HOSPIRA, INC. LAKE FOREST, IL 600…

    Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial. — Recalling firm: Hospira Inc. — Nationwide and Puerto Rico